| 9.00 am | Welcome |
| 9.00 am – 10.20 am | Diagostics/Clinic/Imaging |
|
„The algorithm is seeing you now”-Systematic approach to exophthalmos and update on automated diagnosis making U. Schaudig |
|
|
Ophthalmology meets Radiology: Common language or Babylon U. Müller-Lisse |
|
|
Hertel-Exophthalmometry and beyond A. Klingenstein |
|
|
MRI-Imaging of the orbit: T1, T2 and what else? U. Müller-Lisse |
|
|
Role of DOTA-TATE PET in managing orbital disease A. Klingenstein |
|
| 10.20 am – 11.00 am | Coffee break |
| 11.00 am – 14.30 pm | Orbital lesions I |
|
The problems of how to treat adenoid cystic carcinoma: why we should generally avoid exenteration G. Rose |
|
|
Update on capillary haemangioas L. Baldeschi |
|
|
Surgical treatment of orbital vascular anomalies M. Sales Sanz |
|
|
Update on orbital meningioma treatment C. Schichor |
|
|
VEXAS Syndrome M. Sales Sanz |
|
|
Orbital metastases R. Allen |
|
| 12.30 pm – 1.30 pm | Lunch break |
|
A rationale approach to orbital surgery, routes to different orbital compartment L. Baldeschi |
|
|
Endonasal orbital approaches: Options and risks F. Haubner |
|
|
Use of 3D technology in Oculoplastic and Orbital surgery D. Briscoe |
|
| 2.30 pm – 4.30 pm | Socket |
|
Short introduction into socket issues C. Hintschich |
|
|
Orbital Implants after Enucleation/Evisceration – a German data base A. Schuh |
|
|
Adequate volume replacement – how we got it wrong in the past G. Rose |
|
|
Dermofat grafting: The Munich experience A. Schuh |
|
|
Relining of the whole socket – the „Chevron graft“ technique G. Rose |
|
|
Artificial eye: Critical review of different materials B. Zimmermann |
|
|
Use of temporalis muscle flap in an ophthalmic socket reconstruction M. Sales Sanz |
|
| 4.30 pm – 5.00 pm | Coffee break |
| 5.00 pm – 5.45 pm | Interactive work-shop |
|
Analizing orbital imaging: Radiological differential diagnosis? U. Müller-Lisse & Panel |
|
| 8.30 am – 12.00 am | Thyroid Eye Disease |
|
Evaluation: what really counts A. Eckstein |
|
|
Risk factors for Graves´ Disease – an update R. Gärtner |
|
|
Diagnosing TED-CON: Are we missing something? A. Garip-Kübler |
|
|
Neurofilaments as a tool to detect Optic Neuropathy in TED patients D. Briscoe |
|
|
Latest news on OCT & OCT-Angio A. Garip-Kübler |
|
|
Targeted therapies – theory and practice A. Eckstein |
|
|
Treating TED in the US in the time of teprotumumab R. Allen |
|
| 10.30 am – 11.00 am | Coffee break |
|
Optimal decompression in Thyroid Orbitopathy D. Briscoe |
|
|
Orbital decompression: Tips and tricks L. Baldeschi |
|
|
Functional outcome ofter decompression surgery C. Hintschich |
|
|
Q&A/discussion 222 |
|
| 12.00 am – 1.00 pm | Lunch break |
| 1.00 pm – 2.20 pm | Orbital lesions II |
|
Typical benign and malignant tumors of childhood L. Baldeschi |
|
|
Pediatric orbital inflammation R. Allen |
|
|
Rare Soft Tissue Tumors of the Orbit D. Briscoe |
|
|
Solitary fibrous tumors: results of a monocenter study A. Eckstein |
|
|
New treatment strategies: Checkpoint Inhibitors V. Schmelter |
|
|
IgG4 – what is it all about? G. Rose |
|
| 2.45 pm – 3.15 pm | Coffee break |
| 3.15 pm – 4.30 pm | Cases |
|
Tracing unknows G. Rose, U Schaudig, U Mueller-Lisse & colleagues |
|